Company Overview
Company Name
Insmed
Address
United States
Website
insmed.comPhone
(555) 555-5555Approx. Annual Revenue
$22.0M
Employees
120
Established
1996
About Insmed
Insmed is a United States-based pharmaceutical company with approximately 501 employees. The company focuses on developing innovative and life-transforming medicines for patients with serious and rare diseases. Insmed's approach is driven by a patient-first culture, and its research pipeline includes various treatment candidates targeting significant unmet medical needs.
Business Profile
Read from the Insmed website on Oct 25, 2026. Hover an item to see the exact wording it came from.
About the website
- Website quality (AI-assessed)
- 9/10 · Current copyright 2026; Complete navigation and content
- Footer copyright year
- 2026
Recent changes
What changed on the Insmed website and Google listing, as detected by Coldlytics on each visit.
Estimated revenue band moved from $25M-100M to $10M-25M
Estimated headcount moved from 251-1000 to 101-250 employees
Google Ads pixel installed
Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.
Find companies by what just changed →Biotech & Life Sciences Companies near NY
- Olatec Therapeuticsolatec.com
- Brooklyn Clinical Researchbrooklynclinicalresearch.com
- Pfizerseagen.com
- Stoke Therapeuticsstoketherapeutics.com
- Clinilabsclinilabs.com
- Elevation Oncologyelevationoncology.com
- MindMedmindmed.co
- Anavex Life Sciencesanavex.com
- BioXcel Therapeuticsbioxceltherapeutics.com
- Agile Therapeuticsagiletherapeutics.com
Frequently Asked Questions about Insmed
Advertising Pixels
- Facebook Ad Pixel
- Google Ad Pixel
- LinkedIn Ad Pixel
Categories
Technologies Used
%20--%3e%3csvg%20version='1.1'%20id='st_x5F_cc_x5F_app_x5F_RGB.svg'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%20240.0004%20234.0004'%20style='enable-background:new%200%200%20240.0004%20234.0004;'%20xml:space='preserve'%3e%3cstyle%20type='text/css'%3e%20.st0{fill:url(%23SVGID_1_);}%20.st1{fill:%23FFFFFF;}%20%3c/style%3e%3clinearGradient%20id='SVGID_1_'%20gradientUnits='userSpaceOnUse'%20x1='119.9997'%20y1='234.0002'%20x2='119.9997'%20y2='0.0002'%3e%3cstop%20offset='0'%20style='stop-color:%23201F21'/%3e%3cstop%20offset='1'%20style='stop-color:%23313131'/%3e%3c/linearGradient%3e%3crect%20x='-0.0003'%20y='0.0002'%20class='st0'%20width='240'%20height='234'/%3e%3cg%3e%3cpath%20class='st1'%20d='M132.24969,97.95853c-5.60328,18.77988-10.28088,36.91208-15.88416,54.63138%20c-3.18081,9.99579-6.66385,19.53729-11.05544,25.59485c-4.84678,6.81497-13.93402,13.32771-24.83743,13.32771%20c-7.72443,0-15.29683-3.63509-15.29683-11.66174c0-4.99789,5.14901-9.69264,9.23837-9.69264%20c2.42339,0,3.63508,1.36282,4.24046,2.42339c3.7862,6.81497,7.42128,10.75229,9.08724,10.75229s3.02878-2.27135,5.7544-12.1151%20l19.82331-73.26013H99.08337c-1.06058-3.18081,0.45427-7.11812,2.27135-7.87554h14.23625%20c2.72562-8.7841,5.92356-17.60862,10.46719-25.63529c6.81497-12.26713,17.7193-21.95976,32.71205-21.95976%20c11.3586,0,16.05333,5.45216,16.05333,12.41917c-0.15111,7.42036-6.66293,11.20656-9.69263,11.20656%20c-2.42247,0-3.63416-1.81709-4.39159-4.39159c-2.57451-9.69263-5.90643-12.57029-7.87555-12.57029%20c-1.9682,0-4.99789,3.63416-8.3289,11.20656c-4.3925,9.54151-7.28729,19.72977-10.01291,29.72464h17.26501%20c1.05966,2.12023,0.15112,6.66385-2.42339,7.87554H132.24969z'/%3e%3c/g%3e%3c/svg%3e)
Social Profiles
Key Decision Makers
Will Lewis CEO
Joylyn Meyer Director Clinical Operations
Marie-Laure Nevoret Executive Director, Clinical Development
Yun Irene G. Senior Clinical Development Director
Saskia Benner Director, Clinical Development
Theresa Quinn Biegel Clinical Trial Manager
Joshua Brown Clinical Trial Manager
Tina Bhatia Global Clinical Trial Manager, Development Operations
Christine Suk Senior Clinical Trial Associate
Rashmi Shah Clinical Trial Manager